N01-NS-02379/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2001	2
2002	2
2003	1
2004	1
2005	2
2006	2
2010	1
2024	0

1

Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial.

Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, Levine SR, Lyden PD. Grotta JC, et al. Stroke. 2001 Mar;32(3):661-8. doi: 10.1161/01.str.32.3.661. Stroke. 2001. PMID: 11239184 Clinical Trial.

2

Treatment of acute ischemic stroke: Part I: recanalization strategies.

Broderick JP, Hacke W. Broderick JP, et al. Circulation. 2002 Sep 17;106(12):1563-9. doi: 10.1161/01.cir.0000030406.47365.26. Circulation. 2002. PMID: 12234965 Review. No abstract available.

3

Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial.

Tanne D, Levine SR, Brey RL, Lin H, Tilley BC; NINDS rt-PA Stroke Study Group. Tanne D, et al. Neurology. 2003 Oct 28;61(8):1158-9. doi: 10.1212/01.wnl.0000086809.46485.a1. Neurology. 2003. PMID: 14581697 Clinical Trial. No abstract available.

4

Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.

Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR; NINDS rtPA Stroke Study Group. Tanne D, et al. Stroke. 2006 Jul;37(7):1798-804. doi: 10.1161/01.STR.0000226897.43749.27. Epub 2006 Jun 8. Stroke. 2006. PMID: 16763191

5

The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.

Kwiatkowski T, Libman R, Tilley BC, Lewandowski C, Grotta JC, Lyden P, Levine SR, Brott T; National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Kwiatkowski T, et al. Ann Emerg Med. 2005 Apr;45(4):377-84. doi: 10.1016/j.annemergmed.2004.06.021. Ann Emerg Med. 2005. PMID: 15795715 Clinical Trial.

6

Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.

Rhoney DH, Coplin WM, Lin Y, Frankel M, Lyden PD, Levine SR. Rhoney DH, et al. J Stroke Cerebrovasc Dis. 2010 Jan;19(1):40-8. doi: 10.1016/j.jstrokecerebrovasdis.2009.03.006. J Stroke Cerebrovasc Dis. 2010. PMID: 20123226 Clinical Trial.

7

Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study.

Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR; NINDS rt-PA Stroke Study Group. Jauch EC, et al. Stroke. 2006 Oct;37(10):2508-13. doi: 10.1161/01.STR.0000242290.01174.9e. Epub 2006 Sep 7. Stroke. 2006. PMID: 16960091

8

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Hacke W, et al. Lancet. 2004 Mar 6;363(9411):768-74. doi: 10.1016/S0140-6736(04)15692-4. Lancet. 2004. PMID: 15016487

9

Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial.

Lu M, Tilley BC; NINDS t-PA Stroke Trial Study Group. Lu M, et al. Stat Med. 2001 Jul 15;20(13):1891-901. doi: 10.1002/sim.841. Stat Med. 2001. PMID: 11427947

10

Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.

National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group. National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group. Ann Emerg Med. 2005 Sep;46(3):243-52. doi: 10.1016/j.annemergmed.2005.02.013. Ann Emerg Med. 2005. PMID: 16126134 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year